TG Therapeutics raises 2026 annual global revenue guidance to $1 billion
TGTX TG Therapeutics Inc
$64.51 -0.08%
View chart & analysis → - 1TG Therapeutics raised its 2026 annual global revenue guidance to $1 billion.
- 2TG Therapeutics recorded a 52% year-over-year increase in U.S. BRIUMVI net product sales in the third quarter.
- 3TG Therapeutics achieved $233 million in U.S. net product sales in the third quarter.
So what's the key point?
TG Therapeutics has increased its expected global revenue for 2026 to $1 billion. Sales in the U.S. have grown significantly, suggesting higher future earnings.
Source The Motley Fool +1 · View original ↗
Nothing hidden: past picks and how they did against the S&P 500.